Home/Filings/4/0001415889-25-010505
4//SEC Filing

Otero Jose Manuel 4

Accession 0001415889-25-010505

CIK 0001907108other

Filed

Apr 8, 8:00 PM ET

Accepted

Apr 9, 5:48 PM ET

Size

5.1 KB

Accession

0001415889-25-010505

Insider Transaction Report

Form 4
Period: 2025-03-14
Otero Jose Manuel
Chief Technical Officer
Transactions
  • Award

    Common Stock

    2025-03-14$2.61/sh+5,720$14,92963,220 total
Footnotes (2)
  • [F1]The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Lexeo Therapeutics, Inc. 2023 Employee Stock Purchase Plan. This transaction is exempt under both Rule 16b-3(c) and Rule 16b-3(d).
  • [F2]Includes 57,500 restricted stock units.

Issuer

Lexeo Therapeutics, Inc.

CIK 0001907108

Entity typeother

Related Parties

1
  • filerCIK 0002024096

Filing Metadata

Form type
4
Filed
Apr 8, 8:00 PM ET
Accepted
Apr 9, 5:48 PM ET
Size
5.1 KB